{"id":"https://openalex.org/W40689377","doi":null,"title":"Antiviral effects of 6-chloro-2',3'-dideoxyguanosine in rhesus monkeys acutely infected with simian immunodeficiency virus.","display_name":"Antiviral effects of 6-chloro-2',3'-dideoxyguanosine in rhesus monkeys acutely infected with simian immunodeficiency virus.","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W40689377","mag":"40689377","pmid":"https://pubmed.ncbi.nlm.nih.gov/9875380"},"language":"en","primary_location":{"id":"pmid:9875380","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9875380","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral chemistry & chemotherapy","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059870950","display_name":"Yuji Fujii","orcid":"https://orcid.org/0000-0003-4613-7232","observed_orcids":["https://orcid.org/0000-0003-4613-7232"]},"institutions":[{"id":"https://openalex.org/I874359049","display_name":"Nippon Paper Industries (Japan)","ror":"https://ror.org/00yzvve44","country_code":"JP","type":"company","lineage":["https://openalex.org/I874359049"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Y Fujii","raw_affiliation_strings":["Iwakuni Research Laboratory of Technology, Nippon Paper Industries, Yamaguchi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Iwakuni Research Laboratory of Technology, Nippon Paper Industries, Yamaguchi, Japan","institution_ids":["https://openalex.org/I874359049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108199098","display_name":"Ryouzaburo Mukai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Mukai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083997812","display_name":"Hirofumi Akari","orcid":"https://orcid.org/0000-0003-2166-6015","observed_orcids":["https://orcid.org/0000-0003-2166-6015"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Akari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081676619","display_name":"Makoto Machida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Machida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041139656","display_name":"Kazuyasu Mori","orcid":"https://orcid.org/0000-0002-1841-6376","observed_orcids":["https://orcid.org/0000-0002-1841-6376"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Mori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003946980","display_name":"MASAO TAKASAKA","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Takasaka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036463979","display_name":"Eiji Kojima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Kojima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111696723","display_name":"K Murakami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Murakami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064231127","display_name":"Yoshie Yoshikawa","orcid":"https://orcid.org/0000-0003-0619-0784","observed_orcids":["https://orcid.org/0000-0003-0619-0784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Yoshikawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2512,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.58077485,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"9","issue":"1","first_page":"85","last_page":"92"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9262999892234802,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9262999892234802,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.07190000265836716,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/simian-immunodeficiency-virus","display_name":"simian immunodeficiency virus","score":0.8709999918937683},{"id":"https://openalex.org/keywords/sivmac239","display_name":"SIVmac239","score":0.9729999899864197},{"id":"https://openalex.org/keywords/antiviral-activity","display_name":"antiviral activity","score":0.6959999799728394},{"id":"https://openalex.org/keywords/acute-viral-infection","display_name":"acute viral infection","score":0.6890000104904175},{"id":"https://openalex.org/keywords/rhesus-macaques","display_name":"rhesus monkeys","score":0.9480000138282776},{"id":"https://openalex.org/keywords/cerebrospinal-fluid-drug-concentration","display_name":"cerebrospinal fluid drug concentration","score":0.8709999918937683},{"id":"https://openalex.org/keywords/lymphadenopathy","display_name":"lymphadenopathy","score":0.7419999837875366},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7049999833106995},{"id":"https://openalex.org/keywords/anti-hiv-agents","display_name":"anti-HIV agents","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C2777995582","wikidata":"https://www.wikidata.org/wiki/Q1890246","display_name":"Simian immunodeficiency virus","level":3,"score":0.9033676981925964},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6568519473075867},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6339019536972046},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5548855066299438},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.5535510182380676},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5512965321540833},{"id":"https://openalex.org/C2775996393","wikidata":"https://www.wikidata.org/wiki/Q1149147","display_name":"Cytopathic effect","level":3,"score":0.5379046201705933},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4929184913635254},{"id":"https://openalex.org/C42533223","wikidata":"https://www.wikidata.org/wiki/Q1378064","display_name":"ED50","level":3,"score":0.4713430106639862},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4408698081970215},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34668147563934326},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29314395785331726},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.278602659702301},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1501510739326477},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08061060309410095},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000956","descriptor_name":"Antigens, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003588","descriptor_name":"Cytopathogenic Effect, Viral","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008253","descriptor_name":"Macaca mulatta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015302","descriptor_name":"Simian Immunodeficiency Virus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015302","descriptor_name":"Simian Immunodeficiency Virus","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D015302","descriptor_name":"Simian Immunodeficiency Virus","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016097","descriptor_name":"Simian Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016097","descriptor_name":"Simian Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018920","descriptor_name":"Coculture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9875380","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9875380","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral chemistry & chemotherapy","raw_type":"Journal Article"},{"id":"mag:40689377","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9875380","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2325111546","https://openalex.org/W2009382402","https://openalex.org/W1973517037","https://openalex.org/W2294424129","https://openalex.org/W4237182459","https://openalex.org/W2281590011","https://openalex.org/W2023161781","https://openalex.org/W2053271615","https://openalex.org/W2952770394","https://openalex.org/W2414272349"],"abstract_inverted_index":{"A":[0,66],"lipophilic":[1],"dideoxynucleoside":[2],"analogue,":[3],"6-chloro-2',3'-dideoxyguanosine":[4],"(6-Cl-ddG),":[5],"was":[6,72,90,99,108,130,164],"expected":[7],"to":[8,74],"be":[9],"effective":[10],"against":[11],"AIDS-related":[12],"dementia.":[13],"In":[14,123],"this":[15,186],"study,":[16],"we":[17],"tested":[18],"the":[19,93,103,105,124,127,145,154,171,181],"effect":[20,48],"of":[21,35,63,68,87,113,159,175,185],"6-Cl-ddG":[22,71,98,176,192],"on":[23,32],"simian":[24],"immunodeficiency":[25,199],"virus":[26,200],"(SIVmac239)":[27],"replication":[28,56],"in":[29,49,57,102,144,161,202],"vitro":[30,58],"and":[31,54,83,141],"acute":[33],"infection":[34],"six":[36],"rhesus":[37],"monkeys":[38,76,89,163],"(Macaca":[39],"mulatta)":[40],"with":[41,59,92,153,170],"SIVmac239.":[42],"This":[43],"compound":[44],"inhibited":[45],"SIV-induced":[46],"cytopathic":[47],"CEM":[50],"x":[51],"174":[52],"cells":[53],"SIV":[55,138],"an":[60,84],"ED50":[61],"value":[62],"2.5":[64],"microM.":[65],"dose":[67],"25":[69],"mg/kg":[70],"administered":[73],"three":[75,88],"every":[77],"8":[78,119],"h":[79,120,135],"for":[80,118,149,166],"10":[81],"days":[82,151,168],"untreated":[85],"group":[86],"injected":[91],"solvent":[94],"without":[95],"drug.":[96],"Although":[97],"not":[100],"detected":[101],"plasma,":[104],"metabolite":[106],"ddG":[107,128],"maintained":[109],"at":[110,133],"a":[111,196],"concentration":[112,129],"more":[114],"than":[115],"3":[116],"microM":[117,132],"after":[121,136,180],"administration.":[122,137],"cerebrospinal":[125],"fluid,":[126],"2":[131,134],"antigen":[139],"(p27)":[140],"antibody":[142],"appearance":[143],"plasma":[146],"were":[147,178],"delayed":[148,165],"5-8":[150],"compared":[152,169],"mock-treated":[155,172],"group.":[156,173],"The":[157,183],"occurrence":[158],"lymphadenopathy":[160],"treated":[162],"6":[167],"Signs":[174],"toxicity":[177],"minimal":[179],"treatment.":[182],"results":[184],"study":[187],"provide":[188],"further":[189],"evidence":[190],"that":[191],"may":[193],"act":[194],"as":[195],"potent":[197],"anti-human":[198],"agent":[201],"vivo.":[203]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}